The Blue Cross and Blue Shield Association licensee is attempting to curtail the delivery of multiple diagnostic imaging exams on a single patient during a single healthcare encounter.
“This type of screening could be used to identify individuals who would benefit from statin medication but are currently untreated," one specialist said. The full analysis will be presented at RSNA 2022 in Chicago.
“The RSNA will maintain our position as the great convener for all those who interact with our members to advance the fields of diagnostic radiology, interventional radiology, radiation oncology and medical physics," Mauro said.
Curtis P. Langlotz, MD, PhD, director of Stanford University's Center for Artificial Intelligence in Medicine and Imaging, will step into the new role.
"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.
